Evidence map›Paper›PMID 26123727›Full record

ArticleHuman mutation2015

WDR73 Mutations Cause Infantile Neurodegeneration and Variable Glomerular Kidney Disease.

Julia Vodopiutz, Rainer Seidl, Daniela Prayer, M Imran Khan, Johannes A Mayr, Berthold Streubel, Jens-Oliver Steiß, Andreas Hahn, Dagmar Csaicsich, Christel Castro and 13 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Human mutation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06729554 (Education & Care in RARE - Efficacy of Targeted Psychoeducational Intervention to Improve Knowledge About Rare Diseases and to Promote Mental Health Among Pediatric Rare Disease Patients), which is not on this map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06729554 narecruitingnot on this mapstarted 2024, after this paper: background citation

Education & Care in RARE - Efficacy of Targeted Psychoeducational Intervention to Improve Knowledge About Rare Diseases and to Promote Mental Health Among Pediatric Rare Disease Patients

TypeinterventionalSponsorMedical University of ViennaRan2024 to 2028Enrolled100ConditionsOrphan Diseases, Rare Disorders, Pediatric Diseases, Inborn Errors of Metabolism DisordersArmsEducation & Care in RARE
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Genetics and phenotypic heterogeneity of Galloway-Mowat syndrome.Cell communication and signaling : CCS · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. NovelFrontiers in molecular neuroscience · 2023
    Article
  11. Genetics of neurosarcoidosis.Journal of neuroimmunology · 2022
    Review
  12. Article
  13. Skin Conditions and Movement Disorders: Hiding in Plain Sight.Movement disorders clinical practice · 2022
    Review
  14. Article
  15. Article
  16. Neurological involvement in monogenic podocytopathies.Pediatric nephrology (Berlin, Germany) · 2021
    Review
  17. Article
  18. Article
  19. Mutations inJournal of the American Society of Nephrology : JASN · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 12 institutions in 7 countries.

Julia VodopiutzDepartment of Pediatrics and Adolescent Medicine, Medical University of Vienna, Austria.
Rainer SeidlDepartment of Pediatrics and Adolescent Medicine, Medical University of Vienna, Austria.
Daniela PrayerDivision of Neuroradiology and Musculoskeletal Radiology, Medical University of Vienna, Austria.
M Imran KhanDepartment of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Johannes A MayrDepartment of Pediatrics, Paracelsus Medical University, Salzburg, Austria.
Berthold StreubelDepartment of Obstetrics and Feto-Maternal Medicine, Medical University of Vienna, Austria.
Jens-Oliver SteißDepartment of Pediatrics, Justus-Liebig-University, Gießen, Germany.
Andreas HahnDepartment of Child Neurology, Justus-Liebig-University, Gießen, Germany.
Dagmar CsaicsichDepartment of Pediatrics and Adolescent Medicine, Medical University of Vienna, Austria.
Christel CastroInserm, UMR_S 910, 13385, Marseille, France.
Mirna AssoumInserm, UMR_S 910, 13385, Marseille, France.
Thomas MüllerDepartment of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Dagmar WieczorekInstitute of Human Genetics, University of Essen, Germany.
Grazia M S ManciniDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Carolin E SadowskiHarvard Medical School, Boston Children's Hospital, Boston, Massachusetts.
Nicolas LévyInserm, UMR_S 910, 13385, Marseille, France.
André MégarbanéUniversité Saint Joseph, Campus des Sciences Médicales, Unité de génétique médicale, Lebanon.
Koumudi GodboleDeenanath Mangeshkar Hospital & Research Center, Erandawane, Pune, India.
Denny SchanzeInstitute of Human Genetics, University Hospital, Magdeburg, Germany.
Friedhelm HildebrandtHarvard Medical School, Boston Children's Hospital, Boston, Massachusetts.
Valérie DelagueInserm, UMR_S 910, 13385, Marseille, France.
Andreas R JaneckeDepartment of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Martin ZenkerInstitute of Human Genetics, University Hospital, Magdeburg, Germany.
Medical University of Vienna · ATInnsbruck Medical University · ATAix-Marseille Université · FRHarvard University · USInserm · FRUniversity of Giessen · DEDeenanath Mangeshkar Hospital and Research Center · INErasmus MC · NLFriedrich-Alexander-Universität Erlangen-Nürnberg · DEParacelsus Medical University · ATSaint Joseph University · LBUniversity Hospital Magdeburg · DE

Funding

Novel genetics, pathobiology & therapy of nephronophthisis-related ciliopathiesR01DK068306 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HILDEBRANDT, FRIEDHELM · 2004 to 2022
$6.6M
Identification and function of new genes causing childhood nephrotic syndromeR01DK076683 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HILDEBRANDT, FRIEDHELM · 2007 to 2021
$5.3M
NIDDK NIH HHS R01 DK068306NIDDK NIH HHS R01 DK076683
6 · The paper itself

Abstract

Infantile-onset cerebellar atrophy (CA) is a clinically and genetically heterogeneous trait. Galloway-Mowat syndrome (GMS) is a rare autosomal recessive disease, characterized by microcephaly with brain anomalies including CA in some cases, intellectual disability, and early-infantile-onset nephrotic syndrome. Very recently, WDR73 deficiency was identified as the cause of GMS in five individuals. To evaluate the role of WDR73 mutations as a cause of GMS and other forms of syndromic CA, we performed Sanger or exome sequencing in 51 unrelated patients with CA and variable brain anomalies and in 40 unrelated patients with a diagnosis of GMS. We identified 10 patients from three CA and from two GMS families with WDR73 mutations including the original family described with CA, mental retardation, optic atrophy, and skin abnormalities (CAMOS). There were five novel mutations, of which two were truncating and three were missense mutations affecting highly conserved residues. Individuals carrying homozygous WDR73 mutations mainly presented with a pattern of neurological and neuroimaging findings as well as intellectual disability, while kidney involvement was variable. We document postnatal onset of CA, a retinopathy, basal ganglia degeneration, and short stature as novel features of WDR73-related disease, and define WDR73-related disease as a new entity of infantile neurodegeneration.

Indexed as

MutationAdolescentAdultAmino Acid SequenceBiopsyBrainChildChild, PreschoolCohort StudiesDNA Mutational AnalysisFemaleGenetic Association StudiesGlomerulonephritisHeredodegenerative Disorders, Nervous SystemHernia, HiatalHumansProteinsWDR73 protein, humanbasal gangliacerebellar atrophyGalloway-Mowatintellectual disabilityoptic atrophyretinopathySCAR5WDR73

Identifiers

PMID26123727
PMCPMC4616260
OpenAlexW1486468021

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.